Effect of Perindopril on Atrial Fibrillation Recurrence and Burden: Results of the Canadian Trial of Atrial Fibrillation (CTAF)-2

BACKGROUND: Hypertension is a risk factor for the development and exacerbation of atrial fibrillation (AF). Angiotensin-converting enzyme inhibitors are a standard-of-care treatment option for patients with hypertension; however, there is conflicting evidence about their effects on AF recurrence. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivard, Lena, Samuel, Michelle, Fortier, Annik, Guertin, Marie-Claude, Khairy, Paul, Roy, Denis, Talajic, Mario, Tardif, Jean-Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531231/
https://www.ncbi.nlm.nih.gov/pubmed/34712936
http://dx.doi.org/10.1016/j.cjco.2021.04.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531231/
https://www.ncbi.nlm.nih.gov/pubmed/34712936
http://dx.doi.org/10.1016/j.cjco.2021.04.014

Ejemplares similares